http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102260177-A

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C219-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
filingDate 2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102260177-A
titleOfInvention Propylene glycol derivatives, preparation method thereof, pharmaceutical composition and use thereof
abstract The invention discloses a new class of propylene glycol derivatives represented by the general formula (I), a preparation method thereof, a pharmaceutical composition containing them, and their use as medicines, especially immunomodulatory medicines. This kind of compound with excellent curative effect and low toxicity can be used for immune disorder and immunosuppression; and can be used for treatment and/or low immunity, rejection after organ transplantation and autoimmune disease. General formula (I)
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105017034-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018033866-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018007919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058696-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9770459-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104844533-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104844533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9115054-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11701373-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018116203-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9487481-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10166249-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10709719-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109665949-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105017034-A
priorityDate 2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006009092-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100391930-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004024673-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100415735-C
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163938386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453922337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467361229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467823286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465701059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56966342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465134494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164005738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467458588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465799804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467039347
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163545668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467778529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419638381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8282

Total number of triples: 52.